The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis
- 1 August 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 64 (2) , 715-719
- https://doi.org/10.1046/j.1523-1755.2003.00120.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cytomegalovirus encodes a potent α chemokineProceedings of the National Academy of Sciences, 1999
- Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failureKidney International, 1999
- Vascular access for hemodialysisKidney International, 1999
- Endothelial Dysfunction, Impaired Endogenous Fibrinolysis, and Cigarette SmokingCirculation, 1999
- Cigarette Smoking and Progression of AtherosclerosisJAMA, 1998
- Enhanced Cellular Proliferation in Intact Stenotic Lesions Derived From Human Arteriovenous Fistulas and Peripheral Bypass GraftsCirculation, 1996
- Hemodialysis vascular access morbidity in the United StatesKidney International, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal DiseaseAnnals of Internal Medicine, 1989
- HIGH LEVELS OF CYTOMEGALOVIRUS ANTIBODY IN PATIENTS REQUIRING VASCULAR SURGERY FOR ATHEROSCLEROSISThe Lancet, 1987